Anticholinergics promote neuroleptic-induced tardive dyskinesia.
D000547:Amantadine / Q000494:pharmacology; D000818:Animals; D014150:Antipsychotic Agents / Q000494:pharmacology*; D001590:Benztropine / Q000494:pharmacology; D003913:Dextroamphetamine / Q000494:pharmacology; D004357:Drug Synergism; D004409:Dyskinesia, Drug-Induced / Q000209:etiology*; D006220:Haloperidol / Q000494:pharmacology; D006801:Humans; D008297:Male; D009043:Motor Activity / Q000187:drug effects; D010276:Parasympatholytics / Q000494:pharmacology*; D051381:Rats; D013239:Stereotyped Behavior / Q000187:drug effects
D014150:Antipsychotic Agents; D010276:Parasympatholytics; D001590:Benztropine; D000547:Amantadine; D006220:Haloperidol; D003913:Dextroamphetamine